Standardised methods (immunohistochemical protocol, antibody, and IHC platform), whole section tissue samples and training could deeply impact on PD‐L1 evaluation and the concordance between different anti‐PD‐L1 antibodies in HNSCC patients. Here, CD274 is linked to head and neck squamous cell carcinoma.